4.09
-0.01(-0.24%)
Currency In USD
Address
525 Executive Boulevard
Elmsford, NY 10523
United States of America
Phone
914 233 3004
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
31
First IPO Date
May 28, 2015
| Name | Title | Pay | Year Born |
| Dr. Doron Robert Besser M.D. | Chief Executive Officer & Director | 0 | 1969 |
| Dr. Harold Jacob M.D. | Chief Medical Officer | 10,000 | 1954 |
| Mr. Stephen R. Brown CPA | Chief Financial Officer | 279,792 | 1956 |
| Ms. Rita Silberberg | Executive Vice President of Finance, Chief Accounting Officer & Corporate Secretary | 0 | 1975 |
| Ms. Lindsey Harrison | Vice President of Sales | 0 | N/A |
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.